Skip to main navigation

About us

Our Approach

Our Pipeline

Patients

Investors

Careers

About us

Our Approach

Our Pipeline

Patients

Investors

Careers

Corporate Presentation

Stock Information

Stock Quote & Chart

Analyst Coverage

Corporate Governance

Governance Overview

Board of Directors

Financial Information

SEC Filings - AGLE

Quarterly Results

Contact IR

Investor Relations Contact:

eric.mcintyre@spyre.com

Our Approach
Approach
Therapeutic Targets
Half-life Extension
Rational Combinations
Publications

Our Programs
Pipeline
Programs

Investors
Corporate Presentation
Overview
News & Events
Stock Information
Financial Information
Corporate Governance
IR Resources

Patients
Spyre Commitment
Clinical Trials & Disease Ed

Careers
Values
Benefits
Careers

About Us
People
Contact

to stay updated

Terms of Service
Privacy Policy

© 2026 Spyre Therapeutics. All rights reserved. For U.S. residents only.

Design and development by Visual Science